======= DPH5 ======= == Gene Information == * **Official Symbol**: DPH5 * **Official Name**: diphthamide biosynthesis 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51611|51611]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H2P9|Q9H2P9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DPH5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPH5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611075|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: S-adenosyl-L-methionine-dependent methyltransferase that catalyzes four methylations of the modified target histidine residue in translation elongation factor 2 (EF-2), to form an intermediate called diphthine methyl ester. The four successive methylation reactions represent the second step of diphthamide biosynthesis. {ECO:0000250|UniProtKB:P32469, ECO:0000269|PubMed:23486472}. |TP methylase| |diphthine synthase activity| |peptidyl-diphthamide metabolic process| |peptidyl-diphthamide biosynthetic process from peptidyl-histidine| |peptidyl-histidine modification| |regulation of cytoplasmic translational elongation| |regulation of translational elongation| |regulation of cytoplasmic translation| |methylation| |regulation of translation| |regulation of cellular amide metabolic process| |cellular component| |posttranscriptional regulation of gene expression| |peptidyl-amino acid modification| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.81| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|-2.48| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.3| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.27| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.27| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-2.05| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.96| |[[:results:exp481|Ethambutol 25μM R08 exp481]]|-1.85| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.75| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.72| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|1.72| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.75| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.78| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.79| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.79| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.79| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.81| |[[:results:exp211|AICAR 240μM R05 exp211]]|1.82| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.84| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|1.87| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.9| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.91| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|1.93| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.95| |[[:results:exp359|FK-506 30μM R07 exp359]]|1.96| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.96| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.97| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.02| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|2.04| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|2.05| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.28| |[[:results:exp275|Citral 75μM R06 exp275]]|2.31| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.35| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.41| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.54| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.57| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.78| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.8| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.86| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|3.04| |[[:results:exp135|MS023 7μM R03 exp135]]|3.25| |[[:results:exp274|Citral 50μM R06 exp274]]|3.3| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|3.4| |[[:results:exp134|MS023 2μM R03 exp134]]|3.4| |[[:results:exp85|UM0129480 7μM R02 exp85]]|4.01| ^Gene^Correlation^ |[[:human genes:d:dph1|DPH1]]|0.759| |[[:human genes:d:dph6|DPH6]]|0.694| |[[:human genes:d:dnajc24|DNAJC24]]|0.692| |[[:human genes:d:dph2|DPH2]]|0.685| |[[:human genes:d:dph3|DPH3]]|0.535| |[[:human genes:m:mapkap1|MAPKAP1]]|0.474| |[[:human genes:u:urm1|URM1]]|0.469| |[[:human genes:e:elp2|ELP2]]|0.458| |[[:human genes:m:mocs3|MOCS3]]|0.457| |[[:human genes:p:pik3cd|PIK3CD]]|0.456| |[[:human genes:c:ctu1|CTU1]]|0.437| |[[:human genes:c:cd81|CD81]]|0.437| |[[:human genes:k:kti12|KTI12]]|0.437| |[[:human genes:c:cd19|CD19]]|0.428| |[[:human genes:n:nr2c2ap|NR2C2AP]]|0.427| |[[:human genes:e:elp6|ELP6]]|0.424| |[[:human genes:c:cxorf56|CXorf56]]|0.417| |[[:human genes:y:ythdf2|YTHDF2]]|0.416| |[[:human genes:e:elp3|ELP3]]|0.415| |[[:human genes:z:zzz3|ZZZ3]]|0.411| |[[:human genes:p:prim1|PRIM1]]|0.401| |[[:human genes:s:slc7a1|SLC7A1]]|0.4| |[[:human genes:k:kdsr|KDSR]]|0.4| Global Fraction of Cell Lines Where Essential: 5/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|2/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9812 * **Expression level (log2 read counts)**: 5.29 {{:chemogenomics:nalm6 dist.png?nolink |}}